NMO Spectrum disorders

Second lecture of session V - Long-term observation of diseases at the border of MS and pediatric MS, presented at the 26th Annual Meeting on Friday 16 November 2018.
Chair: Prof Dr Krzysztof Selmaj.

Log in or create an account to watch this content

Subscribe now and get unlimited access to all webinars and recordings.

Log in
Create an account

Now Playing: NMO Spectrum disorders

Kazuo Fujihara - Nov 15, 2018

Other recordings

Comi_G_2018_David plas 155341

Opening XXVI th Annual Meeting of The European Charcot Foundation by Giancarlo Comi

Nov 15, 2018
Opening 26th Annual Meeting of The European Charcot Foundation.​
Watch now
Trojano_M_2018_David plas 155671

XXVI Annual Meeting Opening Lecture

Nov 15, 2018
The role of long-term clinical studies in defining DMTs' profile
Watch now
Sormani_M P_2018_David plas 156321

Statistical Problems

Nov 15, 2018
First lecture of Session I - Values and limits of long-term clinical studies, presented at the 26th Annual Meeting on Thursday 15 November 2018.
Watch now
Kappos_L_2018_David plas 156591

Methodology of extension studies

Nov 15, 2018
Second lecture of Session I - Values and limits of long-term clinical studies, presented at the 26th Annual Meeting on Thursday 15 November 2018.
Watch now
Peeters_L_2018_David plas 156921

Big data handling

Nov 15, 2018
Third lecture of Session I - Values and limits of long term clinical studies, presented at the 26th Annual Meeting on Thursday 15 November 2018.
Watch now
Lawton_M_2018_David plas 15707_BW

The use of multi-level modelling to produce virtual placebo groups for long-term assesment of MS drug effectiveness: experience from the risk sharing scheme

Nov 15, 2018
Fourth lecture of Session I - Values and limits of long-term clinical studies, presented at the 26th Annual Meeting on Thursday 15 November 2018.
Watch now
Cree_B A_2018_David plas 158111

The UCSF experience

Nov 15, 2018
First lecture of Session II - Long-lasting post-marketing studies in relapsing MS, presented at the 26th Annual Meeting on Thursday 15 November 2018.
Watch now
Dalla Costa_G_2018_David plas 158341

Clinically isolated syndrome

Nov 15, 2018
Second lecture of Session II - Long-lasting post-marketing studies in relapsing MS, presented at the 26th Annual Meeting on Thursday 15 November 2018.
Watch now
Iaffaldino_P_2018_David plas 158621

The Italian MS Registry

Nov 15, 2018
Third lecture of session II - Long-lasting post-marketing studies in Relapsing MS, presented at the 26th Annual Meeting on Thursday 15 November 2018.
Watch now
Rojas_J I_2018_David plas 159091

RelevarEM: the first MS national registry in Argentina and LATAM

Nov 15, 2018
Fourth lecture of Session II - Long-lasting post-marketing studies in relapsing MS, presented at the 26th Annual Meeting on Thursday 15 November 2018.
Watch now
Lorscheider_J_2018_David plas 164111

Secondary Progressive MS

Nov 15, 2018
First lecture of Session III - Progressive MS in post-marketing studies, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Signori_A_2018_David plas 164461

Primary Progressive MS

Nov 15, 2018
Second lecture of Session III - Progressive MS in post-marketing studies, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Hillert_J_2018_David plas 165171

The experience of the Swedish National Registry

Nov 15, 2018
Fourth lecture of session IV - Progressive MS in post-marketing studies, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Hartung_H P _2018_David plas 167341

Interferons and GA

Nov 15, 2018
First lecture of session IV - Extension studies of DMTs, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Sorensen_P S_2018_David plas 167391

Oral treatments

Nov 15, 2018
Second lecture of session IV - Extension studies of DMTs, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Montalban_X_2018_David plas 167621

Antibody treatments

Nov 15, 2018
Third lecture of session IV - Extension studies of DMTs, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Kubala Havrdova_E_2018_David plas 167881

Natalizumab and BMT

Nov 15, 2018
Fourth lecture of session IV - Extension studies of DMTs, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Palace_J_2018_David plas 168721

Anti-MOG

Nov 15, 2018
First lecture of session V - Long-term observation of diseases at the border of MS and pediatric MS, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Ghezzi_A_2018_David plas 169231

Pediatric MS

Nov 15, 2018
Third lecture of session V - Long-term observation of diseases at the border of MS and pediatric MS, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Magyari_M_2018_David plas 169391

Nationwide real world experience with pediatric onset MS

Nov 15, 2018
Fourth lecture of session V - Long-term observation of diseases at the border of MS and pediatric MS, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Khella_S_L_2018_David plas 170811

Methodological aspects

Nov 15, 2018
First lecture of session VI - Assessing safety, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Freedman_M_2018_David plas 171341

DMTs and infections

Nov 15, 2018
Second lecture of session VI - Assessing safety, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Boyko_A_2018_David plas 171801

DMTs and risk of cancer

Nov 15, 2018
Third lecture of session VI - Assessing safety, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Vukusic_S_2018_David plas 172101

DMTs and reproduction

Nov 15, 2018
Fourth lecture of session VI - Assessing safety, presented at the 26th Annual Meeting on Friday 16 November 2018.
Watch now
Schippling_S_2018_David plas 174761

OCT

Nov 15, 2018
First lecture of session VII - What long-term instrumental studies are telling us about impact of DMTs, presented at the 26th Annual Meeting on Saturday 17 November 2018.
Watch now
Leocani_L_2018_David plas 175191

EPS

Nov 15, 2018
Second lecture of session VII - What long-term instrumental studies are telling us about impact of DMTs, presented at the 26th Annual Meeting on Saturday 17 November 2018.
Watch now
Fazekas_F_2018_David plas 175431

Brain MRI

Nov 15, 2018
Third lecture of session VII - What long-term instrumental studies are telling us about impact of DMTs, presented at the 26th Annual Meeting on Saturday 17 November 2018.
Watch now
Tsagkas_C_2018_David plas 175561

Spinal cord MRI

Nov 15, 2018
Fourth lecture of session VII - What long-term instrumental studies are telling us about impact of DMTs, presented at the 26th Annual Meeting on Saturday 17 November 2018.
Watch now
Vermersch_P_2018_David plas 177451

Patient reported outcomes

Nov 15, 2018
First lecture of session VIII - Long-term effects of management of MS, presented at the 26th Annual Meeting on Saturday 17 November 2018.
Watch now
Langdon_D_2018_David plas 177771

Long-term studies of cognitive dysfunctions in MS

Nov 15, 2018
Second lecture of session VIII - Long-term effects of management of MS, presented at the 26th Annual Meeting on Saturday 17 November 2018.
Watch now
Uitdehaag_B_2018_David plas 178061

Fatigue

Nov 15, 2018
Third lecture of session VIII - Long-term effects of management of MS, presented at the 26th Annual Meeting on Saturday 17 November 2018.
Watch now
Feinstein_A_2018_David plas 178181

Depression

Nov 15, 2018
Fourth lecture of session VIII - Long-term effects of management of MS, presented at the 26th Annual Meeting on Saturday 17 November 2018.
Watch now